Your browser doesn't support javascript.
loading
Caveolin-1 protects against liver damage exacerbated by acetaminophen in non-alcoholic fatty liver disease by inhibiting the ERK/HIF-1α pathway.
You, Tingyu; Li, Yu; Li, Bowen; Wu, Shuai; Jiang, Xiangfu; Fu, Dongdong; Xin, Jiao; Huang, Yan; Jin, Lei; Hu, Chengmu.
Afiliação
  • You T; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, China; Key Laboratory of Anti-inflammatory and Immune Med
  • Li Y; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, China; Key Laboratory of Anti-inflammatory and Immune Med
  • Li B; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, China; Key Laboratory of Anti-inflammatory and Immune Med
  • Wu S; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, China; Key Laboratory of Anti-inflammatory and Immune Med
  • Jiang X; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, China; Key Laboratory of Anti-inflammatory and Immune Med
  • Fu D; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, China; Key Laboratory of Anti-inflammatory and Immune Med
  • Xin J; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, China; Key Laboratory of Anti-inflammatory and Immune Med
  • Huang Y; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, China; Key Laboratory of Anti-inflammatory and Immune Med
  • Jin L; Department of Infectious diseases, The Second Affiliated Hospital of Anhui Medical University, China. Electronic address: jinlei198510@126.com.
  • Hu C; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei, China; Key Laboratory of Anti-inflammatory and Immune Med
Mol Immunol ; 163: 104-115, 2023 11.
Article em En | MEDLINE | ID: mdl-37769575

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Hepática Induzida por Substâncias e Drogas / Hepatopatia Gordurosa não Alcoólica Limite: Animals Idioma: En Revista: Mol Immunol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Hepática Induzida por Substâncias e Drogas / Hepatopatia Gordurosa não Alcoólica Limite: Animals Idioma: En Revista: Mol Immunol Ano de publicação: 2023 Tipo de documento: Article